24.01: Impact of 123I-BMIPP on prognosis of nonobstructive hypertrophic cardiomyopathy: From 10 years follow-up data
Noboru Fujino(Kanazawa University), Masakazu Yamagishi, Katsuharu Uchiyama(Kouseiren Takaoka Hospital), Kenichi Nakajima(Kanazawa University), Eiichi Masuta(Kanazawa University), Hidekazu Ino(Kanazawa University), Kenshi Hayashi(Kanazawa University), Kenji Sakata(Kanazawa University), Shinro Matsuo(Shiga University of Medical Science), Yuki Sakamoto(Kobe University), A. Muramoto(Kanazawa University), T Tsubokawa(Kanazawa University), Akira Funada(National Cerebral and Cardiovascular Center)
Cited by 0
Related Papers
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
T‐peak to T‐end interval may be a better predictor of high‐risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin i mutation than qt dispersion
|Clinical Cardiology|2002|267
Collagen remodelling in myocardia of patients with diabetes.
|Journal of Clinical Pathology|1993|247
Mitochondrial mutation in fatal infantile cardiomyopathy
|The Lancet|1990|168